| Style | Citing Format |
|---|---|
| MLA | Shabaninejad V, et al.. "Assessing Ptv Margins in Prostate Cancer Tomotherapy; a Comprehensive Analysis of Interfractional Motion and Factors Affecting Prostate and Oar Displacement Type of Study." Immunopathologia Persa, vol. 12, no. 2, 2026, pp. 1-7. |
| APA | Shabaninejad V, Shanei A, Roayaei M, Akhavan A, Saeb M (2026). Assessing Ptv Margins in Prostate Cancer Tomotherapy; a Comprehensive Analysis of Interfractional Motion and Factors Affecting Prostate and Oar Displacement Type of Study. Immunopathologia Persa, 12(2), 1-7. |
| Chicago | Shabaninejad V, Shanei A, Roayaei M, Akhavan A, Saeb M. "Assessing Ptv Margins in Prostate Cancer Tomotherapy; a Comprehensive Analysis of Interfractional Motion and Factors Affecting Prostate and Oar Displacement Type of Study." Immunopathologia Persa 12, no. 2 (2026): 1-7. |
| Harvard | Shabaninejad V et al. (2026) 'Assessing Ptv Margins in Prostate Cancer Tomotherapy; a Comprehensive Analysis of Interfractional Motion and Factors Affecting Prostate and Oar Displacement Type of Study', Immunopathologia Persa, 12(2), pp. 1-7. |
| Vancouver | Shabaninejad V, Shanei A, Roayaei M, Akhavan A, Saeb M. Assessing Ptv Margins in Prostate Cancer Tomotherapy; a Comprehensive Analysis of Interfractional Motion and Factors Affecting Prostate and Oar Displacement Type of Study. Immunopathologia Persa. 2026;12(2):1-7. |
| BibTex | @article{ author = {Shabaninejad V and Shanei A and Roayaei M and Akhavan A and Saeb M}, title = {Assessing Ptv Margins in Prostate Cancer Tomotherapy; a Comprehensive Analysis of Interfractional Motion and Factors Affecting Prostate and Oar Displacement Type of Study}, journal = {Immunopathologia Persa}, volume = {12}, number = {2}, pages = {1-7}, year = {2026} } |
| RIS | TY - JOUR AU - Shabaninejad V AU - Shanei A AU - Roayaei M AU - Akhavan A AU - Saeb M TI - Assessing Ptv Margins in Prostate Cancer Tomotherapy; a Comprehensive Analysis of Interfractional Motion and Factors Affecting Prostate and Oar Displacement Type of Study JO - Immunopathologia Persa VL - 12 IS - 2 SP - 1 EP - 7 PY - 2026 ER - |